SEM
ELV icon

Strategic Equity Management’s Elevance Health ELV Stock Holding History

Strategic Equity Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-442
Closed -$203K – 39
2023
Q1 		$203K Hold
442
– – 0.07% 42
2022
Q4 		$227K Sell
442
-73
-14% -$37.1K 0.09% 34
2022
Q3 		$234K Hold
515
– – 0.1% 35
2022
Q2 		$249K Hold
515
– – 0.13% 35
2022
Q1 		$253K Hold
515
– – 0.09% 37
2021
Q4 		$239K Buy
+515
New +$217K 0.07% 43

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Strategic Equity Management's ELV Position: Q2 2023 in Review

Strategic Equity Management sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 442 shares — an estimated $203K sold.

Strategic Equity Management first reported a position in ELV in Q4 2021 and held it in 6 quarters. The position peaked at $253K in Q1 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Strategic Equity Management reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Strategic Equity Management sold 442 Elevance Health shares in Q2 2023, an estimated $203K.
  • Strategic Equity Management first reported a position in Elevance Health in Q4 2021 and held it in 6 quarters.
  • Strategic Equity Management's Elevance Health position peaked at $253K in Q1 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Strategic Equity Management's 13F filing for Q2 2023, filed 18 Jul 2023.